Market Research Logo

Serbia Pharmaceuticals & Healthcare Q1 2019

Serbia Pharmaceuticals & Healthcare Q1 2019

Key View:

The Serbian pharmaceutical market is among the least developed in the Central and Eastern European region. Lower-value medicines will continue to dominate the market given the low purchasing power of patients and the country’s weakintellectual property laws, weakening opportunities for innovative drugmakers. However, growth will remain positive in the comingyears, supported by an ageing population as well as government efforts to expand and modernise public healthcare.


Key View
SWOT
Industry Forecast
Pharmaceuticals Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Industry Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Galenika
Hemofarm Stada
Serbia Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report